Interleukin (IL)-22 has been increasingly recognized as a promising therapeutic option for various types of diseases. This commentary summarizes the novel mechanistic aspects of IL-22 for the treatment of liver diseases including the study by Chen et al. published in the recent issue of the Theranostics that elucidated the novel function of IL-22 as a mitochondrial protector for the adaptive defense against liver injury.
Hwang, S., Feng, D., Gao, B. (2020). Interleukin-22 acts as a mitochondrial protector. Theranostics, 10(17), 7836-7840. https://doi.org/10.7150/thno.48022.
ACS
Hwang, S.; Feng, D.; Gao, B. Interleukin-22 acts as a mitochondrial protector. Theranostics 2020, 10 (17), 7836-7840. DOI: 10.7150/thno.48022.
NLM
Hwang S, Feng D, Gao B. Interleukin-22 acts as a mitochondrial protector. Theranostics 2020; 10(17):7836-7840. doi:10.7150/thno.48022. https://www.thno.org/v10p7836.htm
CSE
Hwang S, Feng D, Gao B. 2020. Interleukin-22 acts as a mitochondrial protector. Theranostics. 10(17):7836-7840.
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.